Literature DB >> 22277119

Multiple myocardial crypts on modified long-axis view are a specific finding in pre-hypertrophic HCM mutation carriers.

Wessel P Brouwer1, Tjeerd Germans, Maaike C Head, Jolanda van der Velden, Martijn W Heymans, Imke Christiaans, Arjan C Houweling, Arthur A Wilde, Albert C van Rossum.   

Abstract

AIMS: Crypts can be found with cardiovascular magnetic resonance imaging (CMR) in hypertrophic cardiomyopathy (HCM) mutation carriers without hypertrophy (carriers) using a modified two-chamber view through the inferoseptum, but also in other patients and healthy individuals with standard long-axis views. Since it is currently unknown if carriers display a specific crypt morphology, we compared crypts in carriers with other cardiac pathologies (controls). Besides, we aimed to determine the optimal imaging plane for the detection of crypts by comparing modified two-chamber views with standard long-axis views. Finally, we evaluated the accuracy of crypts to identify carriers in HCM family screening. METHODS AND
RESULTS: Standard CMR long-axis views with additional modified two-chamber views were prospectively performed in carriers (n= 43), consecutive CMR control patients (n= 252), and mutation-negative family members (n= 15). Crypts were found in 70% (30/43) of carriers and in 12% (31/252) of controls (P< 0.001). Crypts in carriers showed deeper penetrance into the myocardium compared with controls (74 ± 21% vs. 59 ± 22%, P< 0.01). Detection of two or more crypts had a sensitivity of 51% and specificity of 94% for carriership. Modified two-chamber views doubled the sensitivity to detect crypts compared with standard long-axis views. In family screening, ≥2 crypts had a 100% positive predictive value to identify carriers.
CONCLUSIONS: Multiple crypts in the absence of left ventricular hypertrophy are highly specific for HCM mutation carriership and warrant clinical follow-up. A modified two-chamber view has a superior sensitivity compared with standard long-axis views for crypt detection. CMR may be of additional value to identify carriers in family screening.

Entities:  

Mesh:

Year:  2012        PMID: 22277119     DOI: 10.1093/ehjci/jes005

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  26 in total

Review 1.  Overview of left ventricular outpouchings on cardiac magnetic resonance imaging.

Authors:  Arun Sharma; Sanjeev Kumar
Journal:  Cardiovasc Diagn Ther       Date:  2015-12

2.  Late enhanced computed tomography in Hypertrophic Cardiomyopathy enables accurate left-ventricular volumetry.

Authors:  Christoph Langer; M Both; H Harders; M Lutz; M Eden; C Kühl; B Sattler; O Jansen; P Schaefer; N Frey
Journal:  Eur Radiol       Date:  2014-10-15       Impact factor: 5.315

3.  Could two-dimensional radial strain be considered as a novel tool to identify pre-clinical hypertrophic cardiomyopathy mutation carriers?

Authors:  Gloria Maria Santambrogio; Alessandro Maloberti; Paola Vallerio; Angelica Peritore; Francesca Spanò; Lucia Occhi; Francesco Musca; Oriana Belli; Benedetta De Chiara; Francesca Casadei; Rita Facchetti; Fabio Turazza; Emanuela Manfredini; Cristina Giannattasio; Antonella Moreo
Journal:  Int J Cardiovasc Imaging       Date:  2019-07-18       Impact factor: 2.357

4.  Prevalence and morphology of myocardial crypts in normal and hypertrophied myocardium by computed tomography.

Authors:  Ziad Arow; Mithal Nassar; Daniel Monakier; Abid Assali; Hana Vaknin-Assa; Ran Kornowski; Ashraf Hamdan
Journal:  Int J Cardiovasc Imaging       Date:  2019-03-05       Impact factor: 2.357

5.  A highly accurate method for quantifying LVNC cardiomyophaty.

Authors:  Gregorio Bernabé; José D Casanova; Guillem Casas; Josefa Gonzάlez-Carrillo
Journal:  AMIA Annu Symp Proc       Date:  2021-01-25

Review 6.  Research priorities in sarcomeric cardiomyopathies.

Authors:  Jolanda van der Velden; Carolyn Y Ho; Jil C Tardiff; Iacopo Olivotto; Bjorn C Knollmann; Lucie Carrier
Journal:  Cardiovasc Res       Date:  2015-01-28       Impact factor: 10.787

7.  Three-dimensional speckle tracking echocardiography for the preclinical diagnosis of hypertrophic cardiomyopathy.

Authors:  Mohamed F A Aly; Wessel P Brouwer; Sebastiaan A Kleijn; Albert C van Rossum; Otto Kamp
Journal:  Int J Cardiovasc Imaging       Date:  2014-01-30       Impact factor: 2.357

Review 8.  Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy.

Authors:  Waseem Hindieh; Raymond Chan; Harry Rakowski
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

9.  The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study.

Authors:  Carolyn Y Ho; Sharlene M Day; Steven D Colan; Mark W Russell; Jeffrey A Towbin; Mark V Sherrid; Charles E Canter; John L Jefferies; Anne M Murphy; Allison L Cirino; Theodore P Abraham; Matthew Taylor; Luisa Mestroni; David A Bluemke; Petr Jarolim; Ling Shi; Lynn A Sleeper; Christine E Seidman; E John Orav
Journal:  JAMA Cardiol       Date:  2017-04-01       Impact factor: 14.676

10.  Integrating Genetics and Medicine: Disease-Modifying Treatment Strategies for Hypertrophic Cardiomyopathy.

Authors:  Carolyn Y Ho
Journal:  Prog Pediatr Cardiol       Date:  2016-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.